Central serotonergic hyperresponsivity in late-onset Alzheimer's disease.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 7943465.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The prolactin response to oral d-fenfluramine (30 mg) was measured in nine patients with late-onset Alzheimer's disease and in an elderly comparison group. The serotonin-mediated prolactin response was significantly greater in the patients with Alzheimer's disease than in the comparison group. This finding suggests that central serotonin responsivity is greater in Alzheimer's disease.
Medical subject headings
- Alzheimer Disease
- Fenfluramine
- Prolactin
- Serotonin